نتایج جستجو برای: recombinant streptokinase

تعداد نتایج: 112621  

Abbas Rezaei, Hasan Shemirani

Background: Myocardial infarction (MI) is one of the most common and serious diseases resulting from coronary artery occlusion and major reduction in blood flow. Streptokinase as a thrombolytic is considered the first and most important therapeutic intervention for reperfusion following MI in most countries including Iran. Our previous study showed that, the prevalence of high antibody titers a...

Journal: :The Journal of clinical investigation 1985
S Rajagopalan S L Gonias S V Pizzo

A series of new, covalent polyethylene glycol (PEG)-streptokinase adducts were synthesized and characterized. PEGs with average molecular weights of 2,000, 4,000, and 5,000 were activated with carbonyldiimidazole and coupled to the protein under standardized reaction conditions. Steady-state kinetic analysis demonstrated comparable Km values for the activation of plasminogen by streptokinase, P...

2005
Desire Collen

Background. Staphylokinase (STA), a protein with known profibrinolytic properties, is produced by transduced Staphylococcus aureus strains. In experimental animal models, recombinant staphylokinase (STAR) is less immunogenic and more active toward platelet-rich arterial blood clots than streptokinase. Methods and Results. In the present study, 10 mg STAR given intravenously over 30 minutes was ...

Journal: :Circulation 1993
D Collen F Van de Werf

BACKGROUND Staphylokinase (STA), a protein with known profibrinolytic properties, is produced by transduced Staphylococcus aureus strains. In experimental animal models, recombinant staphylokinase (STAR) is less immunogenic and more active toward platelet-rich arterial blood clots than streptokinase. METHODS AND RESULTS In the present study, 10 mg STAR given intravenously over 30 minutes was ...

ژورنال: Iranian Biomedical Journal 2016
Ilghari, Dariush, Kamyab, Ahmad Reza , Karimi Arzenani, Mohsen, Khamesipour, Ali, Mamnoon, Babak, Naserpour Farivar, Taghi,

Background: Existence of bacterial host cell DNA contamination in biopharmaceutical products is a potential risk factor for patients receiving these drugs. Hence, the quantity of contamination must be controlled under the regulatory standards. Although different methods such as hybridization assays have been employed to determine DNA impurities, these methods are labor, intensive and rather exp...

Journal: :British heart journal 1994
J D Gemmill K J Hogg F G Dunn A P Rae W S Hillis

OBJECTIVE To evaluate the influence of pretreatment streptokinase resistance titre and the concentration of IgG antibodies to streptokinase on the efficacy of thrombolytic drugs containing streptokinase in restoring coronary patency in acute myocardial infarction. DESIGN Comparative observational study. SETTING City general hospital. PATIENTS One hundred and twenty four previously unexpos...

2005
Desire Collen Frans Van de Werf

Background. Staphylokinase (STA), a protein with known profibrinolytic properties, is produced by transduced Staphylococcus aureus strains. In experimental animal models, recombinant staphylokinase (STAR) is less immunogenic and more active toward platelet-rich arterial blood clots than streptokinase. Methods and Results. In the present study, 10 mg STAR given intravenously over 30 minutes was ...

Journal: :iranian journal of immunology 0
hasan shemirani faculty of medicine, isfahan university of medical sciences, isfahan, iran abbas rezaei faculty of medicine, isfahan university of medical sciences, isfahan, iran

background: myocardial infarction (mi) is one of the most common and serious diseases resulting from coronary artery occlusion and major reduction in blood flow. streptokinase as a thrombolytic is considered the first and most important therapeutic intervention for reperfusion following mi in most countries including iran. our previous study showed that, the prevalence of high antibody titers a...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید